Cruciferous vegetables, such as broccoli sprouts could possibly be used to help patients reduce their risk for skin cancer, says study.
The researcher found that instead of eating broccoli to unlock the risk-reduction nutrients, patients should apply small doses of sulforaphane to their skin. Think of it as a broccoli-based sunscreen additive.
Super Foods
Encyclopedia section of medindia gives an introduction to some super foods that help in preventing and controlling cancer
Advertisement
Dickinson said that they are searching for better methods to prevent skin cancer in formats that are affordable and manageable for public use. Sulforaphane may be an excellent candidate for use in the prevention of skin cancer caused by exposure to ultraviolet rays.
The research showed that sulforaphane is a highly adaptable, highly effective agent when it comes to inhibiting cancer-causing pathways (such as the AP-1 protein), while activating chemoprotective genes (such as the Nrf2 gene).
Source: ANI
Source: ANI
Frozen Broccoli's 'lost' Cancer-fighting Powers Restored
University of Illinois scientists have restored the frozen broccoli's ability to form sulforaphane, the cancer-fighting phytochemical present in fresh broccoli.
Advertisement
 Broccoli-Gate Revived By ObamaClearly hitting close to home is Michelle Obama's healthy eating campaign. | Advertisement
|
Advertisement
Recommended Readings
Latest Cancer News
The new study uncovers the efficacy of fixed-duration combination treatment in patients with high-risk leukemia.
The approvals of pipeline drugs such as momelotinib and Vonjo for myelofibrosis (a rare type of blood cancer) over some time will handle the critical unmet needs.
New study highlights the dual role that blood vessels can play in cancer immunotherapy and eliciting anti-tumor immune responses or even preventing breast cancer spread.
New study evaluated the association between exposure to the chemical agent orange and the development of blood cancer with increased bleeding and blood clot formation.
Study suggests two-year immunotherapy treatment for advanced lung cancer may be reasonable